{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:50:33Z","timestamp":1792605033243,"version":"4.5.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Innsbruck and Medical University of Innsbruck"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>While medication is a recognized risk factor of delirium, there is currently a lack of detailed information on managing and preventing medication-induced cases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Aim<\/jats:title>\n            <jats:p>This review summarizes the information provided in neurology guidelines on medication-induced delirium in patients with and without dementia to inform guidance on prevention and management strategies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Method<\/jats:title>\n            <jats:p>A systematic literature review was conducted across 114 neurological and medical organisations, Guideline Central and PubMed. Guidelines, consensus guidelines, white papers, frameworks, protocols, standard procedures, action plans and strategic documents detailing the prevention and management of medication-induced delirium in adults with or without dementia were included. Title and full-text screening was completed independently by two reviewers using PICOS. AGREE II was used to assess reporting quality. A data extraction tool was designed based on the Cochrane Effective Practice and Organization of Care Review Group (EPOC) checklist and a mixed methods approach to synthesis adopted. The systematic review protocol was registered with International Prospective Register of Systematic Reviews (PROSPERO) [ID: CRD42022366025].<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Out of 143 guidelines identified, 30 were included. Information for 140 individual medications was extracted. Medications most frequently cited included sedatives (n\u2009=\u200924\/80%), opioids (n\u2009=\u200922\/73,3%), psychoactive drugs (n\u2009=\u200921\/70%)\u2009+\u2009anti-convulsants (n\u2009=\u200914\/46,7%), anti-cholinergic agents (n\u2009=\u200920\/66,7%), antihistamines (n\u2009=\u200918\/60%), and steroids (n\u2009=\u200916\/53,3%). Despite a consistently high-quality rating (n\u2009=\u200919, 63,3%), the detail provided often lacks specificity about pharmacological mechanisms, individual risk, dosing instructions, associated symptoms, therapeutic alternatives and avoidable drug-drug combinations. In relation to dementia, detailed information on the use of antipsychotics, cholinesterase inhibitors and benzodiazepines was extracted. No papers were excluded based on their quality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>No single guideline contains enough information on the risk, prevention, and management of medication-induced delirium to sufficiently support clinical decision making.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s11096-024-01861-4","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T08:41:50Z","timestamp":1739954510000},"page":"606-623","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Medication-induced causes of delirium in patients with and without dementia: a systematic review of published neurology guidelines"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3670-2357","authenticated-orcid":false,"given":"Anita Elaine","family":"Weidmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gu\u00f0n\u00fd Bj\u00f6rk","family":"Propp\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rut","family":"Matth\u00edasd\u00f3ttir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5488-9261","authenticated-orcid":false,"given":"Ivana","family":"Tadi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5971-8584","authenticated-orcid":false,"given":"P\u00e9tur Sigurdur","family":"Gunnarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9232-6723","authenticated-orcid":false,"given":"Freyja","family":"J\u00f3nsd\u00f3ttir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"issue":"2","key":"1861_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cger.2019.11.001","volume":"36","author":"TT Hasieh","year":"2020","unstructured":"Hasieh TT, Inouye S, Oh ES. Delirium in the Elderly. Clin Geriatr Med. 2020;36(2):183\u201399.","journal-title":"Clin Geriatr Med"},{"key":"1861_CR2","unstructured":"Lourdes Ramirez Echeverria M, Schoo C, Paul M. StatPearls: Delirium. 2022; https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470399\/ Accessed 07 Aug 2024."},{"issue":"6","key":"1861_CR3","doi-asserted-by":"publisher","first-page":"655","DOI":"10.4103\/0971-5916.174546","volume":"142","author":"D Kukreja","year":"2015","unstructured":"Kukreja D, G\u00fcnther U, Popp J. Delirium in the elderly: Current problems with increasing geriatric age. Indian J Med Res. 2015;142(6):655\u201362.","journal-title":"Indian J Med Res"},{"key":"1861_CR4","doi-asserted-by":"crossref","unstructured":"Zhang M, Zhang X, Gao L. et al. Incidence, predictors and health outcomes of delirium in very old hospitalized patients: a prospective cohort study. BMC Geriatr. 2022;22:262.","DOI":"10.1186\/s12877-022-02932-9"},{"issue":"1","key":"1861_CR5","first-page":"3","volume":"1","author":"JP Ospina","year":"2018","unstructured":"Ospina JP, King F IV, Madva E, Celano CM. Epidemiology, Mechanisms, Diagnosis, and Treatment of delirium: A narrative Review. Clin Med Ther. 2018;1(1):3.","journal-title":"Clin Med Ther"},{"key":"1861_CR6","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41572-020-00223-4","volume":"6","author":"JE Wilson","year":"2020","unstructured":"Wilson JE, Mart MF, Cunningham C, et al. Delirium Nat Rev Dis Primers. 2020;6:90.","journal-title":"Delirium Nat Rev Dis Primers"},{"key":"1861_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.zefq.2022.02.001","volume":"169","author":"C van Lieshout","year":"2022","unstructured":"van Lieshout C, Schuit E, Hermes C, et al. Hospitalisation costs and health related quality of life in delirious patients: a scoping review. Z Evid Fortbild Qual Gesundhwes. 2022;169:28\u201338.","journal-title":"Z Evid Fortbild Qual Gesundhwes"},{"key":"1861_CR8","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1002\/alz.12262","volume":"17","author":"I Kinchin","year":"2021","unstructured":"Kinchin I, Mitchell E, Agar M, et al. The economic cost of delirium: A systemtic review and quality assessment. Alzheimers Dement. 2021;17:1026\u201341.","journal-title":"Alzheimers Dement"},{"issue":"10","key":"1861_CR9","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1046\/j.1532-5415.2002.50468.x","volume":"50","author":"DM Fick","year":"2002","unstructured":"Fick DM, Agostini JV, Inouye SK. Delirium superimposed on dementia: a systematic review. J Am Geriatr Soc. 2002;50(10):1723\u201332.","journal-title":"J Am Geriatr Soc"},{"key":"1861_CR10","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.2147\/NDT.S247957","volume":"17","author":"A Nitchingham","year":"2021","unstructured":"Nitchingham A, Caplan GA. Current Challenges in the Recognition and Management of delirium superimposed on dementia. Neuropsychiatr Dis Treat. 2021;17:1341\u201351.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"1","key":"1861_CR11","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.49950","volume":"6","author":"CH Ormseth","year":"2023","unstructured":"Ormseth CH, LaHue SC, Oldham MA, et al. Predisposing and Precipitating Factors Associated with delirium: A Systematic Review. Jama Netw Open. 2023;6(1): e2249950.","journal-title":"Jama Netw Open"},{"key":"1861_CR12","unstructured":"National Institute of Health Research, International prospective register of systematic reviews (PROSPERO). https:\/\/www.crd.york.ac.uk\/prospero\/."},{"key":"1861_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71.","journal-title":"BMJ"},{"key":"1861_CR14","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1177\/0363546513497567","volume":"42","author":"JD Harris","year":"2014","unstructured":"Harris JD, Quatman CE, Manring MM, Siston RA, et al. How to write a systematic review. Am J Sports Med. 2014;42:2761\u20138.","journal-title":"Am J Sports Med"},{"issue":"8","key":"1861_CR15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3928\/00989134-20150723-01","volume":"41","author":"MR Puelle","year":"2015","unstructured":"Puelle MR, Kosar CM, Xu G, et al. The language of delirium: Key words for identifying delirium from medical records. J Gerontol Nurs. 2015;41(8):34\u201342.","journal-title":"J Gerontol Nurs"},{"key":"1861_CR16","doi-asserted-by":"crossref","unstructured":"Slooter AJC, Otte WM, Devlin JW, et al. Updated nomenclature of delirium and acute encephalopathy: statement of ten Societies. 2020. Intensive Care Med. 2020; 46:1020\u20131022.","DOI":"10.1007\/s00134-019-05907-4"},{"key":"1861_CR17","unstructured":"The AGREE Research Trust. Appraisal of Guidelines for Research and Evaluation II (AGREE II) Instrument. 2013. https:\/\/www.agreetrust.org\/wp-content\/uploads\/2013\/10\/AGREE-II-Users-Manual-and-23-item-Instrument_2009_UPDATE_2013.pdf Accessed 19 Sep 2024."},{"key":"1861_CR18","first-page":"27","volume":"6","author":"M Dixon-Woods","year":"2006","unstructured":"Dixon-Woods M, Bonas S, Booth A, et al. How can systematic reviews incorporate qualitative research? A critical perspective Qual Res. 2006;6:27\u201344.","journal-title":"A critical perspective Qual Res"},{"key":"1861_CR19","unstructured":"Cochrane Effective Practice and Organisation of Care Group (EPOC). Data Collection Checklist. 2023 https:\/\/methods.cochrane.org\/ Accessed 19 Sep 2024."},{"key":"1861_CR20","unstructured":"National Institutes for Health and Care Excellence [NICE]. Delirium: prevention, diagnosis, and management (CG103). 2023. https:\/\/www.nice.org.uk\/guidance\/cg103 Accessed 19 Sep 2024."},{"key":"1861_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i1152","volume":"352","author":"MC Brouwers","year":"2016","unstructured":"Brouwers MC, Kerkvliet K, Spithoff K. The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines. BMJ. 2016;352: i1152.","journal-title":"BMJ"},{"key":"1861_CR22","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1056\/NEJMra052321","volume":"354","author":"SK Inouye","year":"2006","unstructured":"Inouye SK. Delirium in Older Persons. N Engl J Med. 2006;354:1157\u201365.","journal-title":"N Engl J Med"},{"key":"1861_CR23","unstructured":"UKCPA: Detection, prevention and treatment of delirium in critically ill patients version 1.2. 2006. https:\/\/www.wyccn.org\/uploads\/6\/5\/1\/9\/65199375\/ukcpa_delirium_2006_1%5b1%5d.pdf Accessed 12 Jan 2024."},{"key":"1861_CR24","doi-asserted-by":"crossref","unstructured":"Australian and New Zealand Society for Geriatric Medicine. Position Statement 13. Derlirium in Older People. Revised 2012. Australas J Ageing. 2016; 35(4):292\u2013292.","DOI":"10.1111\/ajag.12297"},{"key":"1861_CR25","unstructured":"Boyer EW, Liebelt WL, Ganetsky M. Serotonin syndrome (serotonin toxicity). 2023. https:\/\/www.uptodate.com\/contents\/serotonin-syndrome-serotonin-toxicity#:~:text=Serotonin%20syndrome%20encompasses%20a%20spectrum,Patients%20may%20startle%20easily Accessed 19 Sep 2024."},{"key":"1861_CR26","unstructured":"Australian Government. Department of Health and Ageing. Delirium Care Pathways. 2010. https:\/\/www.swslhd.health.nsw.gov.au\/btf\/pdfs\/Education\/Delirium_pathway.pdf Accessed 19 Sep 2024."},{"key":"1861_CR27","doi-asserted-by":"crossref","unstructured":"Potter J, George J, Turner-Stokes L on behalf of British geriatrics Society. The prevention, diagnosis and management of delirium in older people: A concise guideline. 2006. Clin Med, 6:303\u2013308.","DOI":"10.7861\/clinmedicine.6-3-303"},{"key":"1861_CR28","unstructured":"Canadian Coalition for Seniors\u2019 Mental Health [CCSMH]. Guideline on the Assessment and Treatment of Delirium in Older Adults at the End of Life. 2010. https:\/\/ccsmh.ca\/wp-content\/uploads\/2016\/03\/NatlGuideline_DeliriumEOLC.pdf Accessed 19 Sep 2024."},{"key":"1861_CR29","unstructured":"NSW Agency for Clinical Innovation (ACI). ACI Aged Health Network. Key Principles for Care of Confused Hospitalised Older Persons. 2015. https:\/\/aci.health.nsw.gov.au\/__data\/assets\/pdf_file\/0006\/249171\/ACI-CHOPs-Key-principles-care-confused-hospitalised-older-persons.pdf Accessed 19 Sep 2024."},{"key":"1861_CR30","unstructured":"Registered Nurses Association of Ontario [British C]. Delirium, Dementia, and Depression in Older Adults: Assessment and Care. 2016. https:\/\/rnao.ca\/bpg\/guidelines\/assessment-and-care-older-adults-delirium-dementia-and-depression Accessed 19 Sep 2024."},{"key":"1861_CR31","unstructured":"BC Centre for Palliative Care [BCCPA]. B.C. Inter-professional palliative symptom management guidelines. 2019. https:\/\/bc-cpc.ca\/wp-content\/uploads\/2018\/09\/SMGs-interactive-final-Nov-30-compressed.pdf Accessed 19 Sep 2024."},{"key":"1861_CR32","unstructured":"Vanderbilt University Medical Center [VUMC]. Trauma Delirium Management Guideline. 2021. https:\/\/www.vumc.org\/trauma-and scc\/sites\/default\/files\/public_files\/Protocols\/Trauma%20Delirium%20PMG%202021.pdf Accessed 19 Sep 2024."},{"key":"1861_CR33","unstructured":"Hartford HealthCare. Post-Acute Care Delirium and Acute Encephalopathy Pathway. 2022. https:\/\/americandeliriumsociety.org\/assets\/documents\/post-acute-delirlum-and-acute-encephalopathy.pdf Accessed 19 Sep 2024."},{"key":"1861_CR34","unstructured":"Landspitali. Clinical guidelines for the diagnosis, prevention, and treatment of delirium. 2015. https:\/\/www.landspitali.is\/um-landspitala\/fjolmidlatorg\/frettir\/stok-frett\/2015\/05\/13\/Kliniskar-leidbeiningar-um-greiningu-forvarnir-og-medferd-vid-oradi\/ Accessed 19 Sep 2024."},{"key":"1861_CR35","doi-asserted-by":"crossref","unstructured":"Bush SH, Lawlor PG, Ryan K, et al. on behalf of the ESMO Guidelines Committee. Ann Onc, 2018; 29 (Supplement 4): iv143 \u2013 iv165.","DOI":"10.1093\/annonc\/mdy147"},{"key":"1861_CR36","unstructured":"NYU Long Island School of Medicine. Manual for Delirium Assessment and Intervention Version 1.5. 2021. https:\/\/americandeliriumsociety.org\/wp-content\/uploads\/2022\/11\/Manual-for-Delirium-Assessment-and-Intervention.pdf Accessed 19 Sep 2024."},{"key":"1861_CR37","unstructured":"James C, Wood K, Fitzroy-Kelly F, Morton C. Tayside guidance \u2013 Antipsychitics and Benzodiazepines in older adults with dementia and\/or delirium \u2013 inpatient settings. 2020. https:\/\/www.nhstaysideadtc.scot.nhs.uk\/approved\/treat\/dementia\/Tayside_guidance_on_Antipsychotics_dementia.pdf Accessed 19 Sep 2024."},{"key":"1861_CR38","unstructured":"Hertfordshire Partnership NHS (HPFT). Guidelines for the Pharmacological Management of Dementia. 2020. https:\/\/www.hpft.nhs.uk\/media\/5079\/guidelines-pharmacological-management-of-dementia-220920.pdf Accessed 19 Sep 2024."},{"key":"1861_CR39","unstructured":"Danish Health Authority. National Clinical Guideline for prevention and treatment of organic delirium. 2021. https:\/\/www.sst.dk\/-\/media\/Udgivelser\/2021\/NKR-delirium\/Eng-quick-guide_Forebyggelse-og-behandling-af-organisk-delirium.ashx Accessed 19 Sep 2024."},{"key":"1861_CR40","unstructured":"Australian Health ministers\u2019 Advisory Council (AHMAC). Clinical Practice guidelines for the Management of Delirium in older people. 2006. https:\/\/content.health.vic.gov.au\/sites\/default\/files\/migrated\/files\/collections\/policies-and-guidelines\/d\/delirium-cpg---pdf.pdf Accessed 19 Sep 2024."},{"key":"1861_CR41","unstructured":"University Hospitals Birmingham NHS Trust. Guidelines for the Assessment and Care of patients with Known or Suspected dementia or delirium. 2018. https:\/\/hgs.uhb.nhs.uk\/wp-content\/uploads\/DementiaOrDeliriumPatientsGuidelines.pdf Accessed 19 Sep 2024."},{"key":"1861_CR42","unstructured":"American Academy of Nursing (AAN). Twenty-five things nurses and patients should question. 2018. https:\/\/aann.org\/uploads\/about\/AANursing-Choosing-Wisely-List_4_19_18__1.pdf Accessed 19 Sep 2024."},{"key":"1861_CR43","unstructured":"Registered Nurses Association of Ontario [RNAO]. Screening for Delirium, Dementia and Depression in Older Adults. 2003. https:\/\/www.workingwitholderpeople.edu.au\/sites\/rnao-ca\/files\/Screening_for_Delirium_Dementia_and_Depression_in_the_Older_Adult.pdf Accessed 19 Sep 2024."},{"key":"1861_CR44","unstructured":"Scottish Intercollegiate Guideline Network. SIGN 157: Risk reduction and management of delirium. A national clinical guideline. 2019. https:\/\/www.sign.ac.uk\/media\/1423\/sign157.pdf Accessed 19 Sep 2024."},{"issue":"7","key":"1861_CR45","doi-asserted-by":"publisher","first-page":"329","DOI":"10.4103\/0019-5545.224473","volume":"60","author":"S Grover","year":"2018","unstructured":"Grover S, Avasthi A. Clinical Practice Guidelines for Management of Delirium in Elderly. Indian J Psychiatry. 2018;60(7):329. https:\/\/doi.org\/10.4103\/0019-5545.224473.","journal-title":"Indian Journal of Psychiatry"},{"key":"1861_CR46","unstructured":"Canadian Society for Hospital Medicine. Hospital Medicine. Five things physicians and patients should question. 2020. https:\/\/choosingwiselycanada.org\/wp-content\/uploads\/2020\/07\/Hospital-medicine_EN.pdf Accessed 19 Sep 2024."},{"key":"1861_CR47","unstructured":"American Geriatrics Society. Ten things clinicians and patients should question. 2015. https:\/\/cme.dmu.edu\/sites\/default\/files\/Choosing%20Wisely%20-%20American%20Geriatrics%20Society.pdf Accessed 19 Sep 2024."},{"issue":"1","key":"1861_CR48","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5664\/jcsm.3352","volume":"10","author":"JM Hall-Porter","year":"2014","unstructured":"Hall-Porter JM, Schweitzer P, Eisenstein RD, et al. The effect of two benzodiazepine receptor agonist hypnotics on sleep-dependent memory consolidation. J Clin Sleep Med. 2014;10(1):27\u201334.","journal-title":"J Clin Sleep Med"},{"key":"1861_CR49","unstructured":"National Institute for Health and Care Excellence (NICE). Delirium: prevention, diagnosis and management in hospital and long-term care. Clinical guideline [CG103]. 2023. https:\/\/www.nice.org.uk\/guidance\/cg103 Accessed 19 Sep 2024."},{"key":"1861_CR50","unstructured":"The Fraser Health Authority [FHA]. Hospice Palliative care symptom guidelines: Delirium\/ Restlessness. 2006. https:\/\/www.fraserhealth.ca\/-\/media\/Project\/FraserHealth\/FraserHealth\/Health-Professionals\/Professionals-Resources\/Hospice-palliative-care\/07FHSymptomGuidelinesDelirium.pdf Accessed 19 Sep 2024."},{"key":"1861_CR51","unstructured":"Canadian Coalition for Seniors\u2019 Mental Health [CCSMH]. Guideline on the Assessment and Treatment of Delirium in Older Adults at the End of Life. 2006. https:\/\/baycrest.echoontario.ca\/wp-content\/uploads\/2021\/03\/National-Guidelines-for-Seniors-Mental-Health_Delirium-2006.pdf Accessed 19 Sep 2024."},{"key":"1861_CR52","unstructured":"The Mid Yorkshire Hospitals NHS Trust. Delirium Guidelines. 2015. https:\/\/www.yhscn.nhs.uk\/media\/PDFs\/mhdn\/Dementia\/Delirium\/Delirium-Care-Pathway%20mid%20yorks.pdf Accessed 07 Aug 2024."},{"issue":"6","key":"1861_CR53","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1177\/0269881118776738","volume":"32","author":"MX Patel","year":"2018","unstructured":"Patel MX, Sethi FN, Barnes TR, et al. Joint BAP NAPICU evidence-based consensus guidelines for the clinical management of acute disturbance: De-escalation and rapid tranquillisation. J Psychopharmacol. 2018;32(6):601\u201340.","journal-title":"J Psychopharmacol"},{"key":"1861_CR54","unstructured":"Japanese Society of Neurology. Clinical Practice Guideline for Dementia. 2017. https:\/\/www.neurology-jp.org\/guidelinem\/dementia\/documents\/preface.pdf Accessed 11 Dec 2023."},{"key":"1861_CR55","doi-asserted-by":"crossref","unstructured":"Reus VI, Fichtmann LJ, Eyler AE, et al. The American Psychiatric Association Practice Guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia. American Psychiatric Association. 2016.","DOI":"10.1176\/appi.books.9780890426807"},{"issue":"9","key":"1861_CR56","doi-asserted-by":"publisher","first-page":"e825","DOI":"10.1097\/CCM.0000000000003299","volume":"46","author":"JW Devlin","year":"2018","unstructured":"Devlin JW, Skrobik Y, G\u00e9linas CRN, et al. Clinical Practice Guidelines for the prevention and management of pain, agitation\/ sedation, delirium, Immobility, and sleep disruption in adult patients in the ICU. Crit Care Med. 2018;46(9):e825\u201373.","journal-title":"Crit Care Med"},{"key":"1861_CR57","unstructured":"Global Council of Brain health (GCBH) . Preserving Your Brain Health During illness or Surgery:GCBH recommendations to prevent and treat delirium. 2020. https:\/\/www.aarp.org\/content\/dam\/aarp\/health\/brain_health\/2020\/03\/gcbh-delirium-report-english.doi.10.26419-2Fpia.00101.001.pdf Accessed 19 Sep 2024."},{"key":"1861_CR58","unstructured":"Australian Commission on safety and quality in health care. Delirium: Fact Sheet for clinicians. 2021. https:\/\/www.safetyandquality.gov.au\/sites\/default\/files\/2021-09\/acsqhc_ccs_delirium_clinicians_fact_sheet_d2.pdf Accessed 19 Sep 2024."},{"key":"1861_CR59","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/ageing\/afq140","volume":"40","author":"A Clegg","year":"2011","unstructured":"Clegg A, Young JB. Which medications to avoid in people at risk of delirium: a systematic review. Age Ageing. 2011;40:23\u20139.","journal-title":"Age Ageing"},{"key":"1861_CR60","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2165\/00003495-199958030-00002","volume":"58","author":"S Dhein","year":"1999","unstructured":"Dhein S, Salameh A, Berkels R, et al. Dual mode of action of Dihydropyridine calcium antagonists. Drugs. 1999;58:397\u2013404.","journal-title":"Drugs"},{"issue":"5","key":"1861_CR61","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/ana.21937","volume":"67","author":"B Ritz","year":"2010","unstructured":"Ritz B, Rhodes SL, Qian L, et al. L-type calcium channel blockers and Parkinson disease in Denmark. Ann Neurol. 2010;67(5):600\u20136.","journal-title":"Ann Neurol"},{"key":"1861_CR62","doi-asserted-by":"crossref","unstructured":"Mena MA, Garcia de Y\u00e9benes MJ, Tabernero C, et al. Effects of calcium antagonists on the dopamine system. Clin Neuropharmacol. 1995;18(5):410\u201326.","DOI":"10.1097\/00002826-199510000-00004"},{"issue":"9","key":"1861_CR63","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s00702-021-02389-x","volume":"129","author":"J Koschel","year":"2022","unstructured":"Koschel J, Ray Chaudhuri K, T\u00f6nges L, et al. Implications of dopaminergic medication withdrawal in Parkinson\u2019s disease. J Neural Transm (Vienna). 2022;129(9):1169\u201378.","journal-title":"J Neural Transm (Vienna)"},{"key":"1861_CR64","unstructured":"Soileu MJ, Furr-Simming EE. Inpatient Management of Parkinson\u2019s Disease. Practical Neurology. 2014; 29\u201331. https:\/\/practicalneurology.com\/articles\/2014-oct\/inpatient-management-of-parkinsons-disease. Accessed 19 Sep 2024."},{"issue":"2","key":"1861_CR65","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s40268-018-0230-3","volume":"18","author":"M Auffret","year":"2018","unstructured":"Auffret M, Drapier S, V\u00e9rin M. The many faces of apomorphine: lessons from the past and challenges for the future. Drugs R D. 2018;18(2):91\u2013107.","journal-title":"Drugs R D"},{"issue":"4","key":"1861_CR66","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/psyg.12324","volume":"18","author":"SRF Ritter","year":"2018","unstructured":"Ritter SRF, Cardoso AF, Lins MMP, et al. Underdiagnosis of delirium in the elderly in acute care hospital settings: lessons not learned. Psychogeriatrics. 2018;18(4):268\u201375.","journal-title":"Psychogeriatrics"},{"issue":"11","key":"1861_CR67","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1001\/jama.1996.03530350034031","volume":"275","author":"SK Inouye","year":"1996","unstructured":"Inouye SK, Charpentier PA. Precipitating factors for delirium in hospitalized elderly persons: predictive model and interrelationship with baseline vulnerability. JAMA. 1996;275(11):852\u20137.","journal-title":"JAMA"},{"issue":"1","key":"1861_CR68","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41572-020-00223-4","volume":"6","author":"JE Wilson","year":"2020","unstructured":"Wilson JE, Mart MF, Cunningham C, et al. Delirium. Nat Rev Dis Primers. 2020;6(1):90.","journal-title":"Nat Rev Dis Primers"},{"key":"1861_CR69","doi-asserted-by":"crossref","unstructured":"Lauretani F, Bellelli G, Pel\u00e0 G et al. Treatment of Delirium in Older Persons: What We Should Not Do! Int J Mol Sci. 2020; 21(7):2397.","DOI":"10.3390\/ijms21072397"},{"key":"1861_CR70","doi-asserted-by":"crossref","unstructured":"Soiza RL, Myint PK. The Scottish Intercollegiate Guidelines Network (SIGN) 157: guidelines on risk reduction and management of delirium.\u00a02019; https:\/\/www.sign.ac.uk\/media\/1423\/sign157.pdf Accessed 19 Sep 2024.","DOI":"10.3390\/medicina55080491"},{"issue":"4","key":"1861_CR71","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/jgs.14076","volume":"64","author":"KJ Neufeld","year":"2016","unstructured":"Neufeld KJ, Yue J, Robinson TN, et al. Antipsychotic Medication for Prevention and Treatment of Delirium in Hospitalized Adults: A Systematic Review and Meta-Analysis. J Am Geriatr Soc. 2016;64(4):705\u201314.","journal-title":"J Am Geriatr Soc"},{"key":"1861_CR72","doi-asserted-by":"crossref","unstructured":"Faeder M, Hale E, Hedayati D et al. Preventing and treating delirium in clinical settings for older adults. Ther Adv Psychopharmacol. 2023;13.","DOI":"10.1177\/20451253231198462"},{"issue":"30","key":"1861_CR73","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000021043","volume":"99","author":"S Xu","year":"2020","unstructured":"Xu S, Cui Y, Shen J, et al. Suvorexant for the prevention of delirium: A meta-analysis. Medicine (Baltimore). 2020;99(30): e21043.","journal-title":"Medicine (Baltimore)"},{"key":"1861_CR74","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.genhosppsych.2023.03.010","volume":"83","author":"A Matsuoka","year":"2023","unstructured":"Matsuoka A, Sogawa R, Murakawa-Hirachi T, et al. Evaluation of the delirium preventive effect of dual orexin receptor antagonist (DORA) in critically ill adult patients requiring ventilation with tracheal intubation at an advanced emergency center: A single-center, retrospective, observational study. Gen Hosp Psychiatry. 2023;83:123\u20139.","journal-title":"Gen Hosp Psychiatry"},{"issue":"3","key":"1861_CR75","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/anae.14472","volume":"74","author":"KT Ng","year":"2019","unstructured":"Ng KT, Shubash CJ, Chong JS. The effect of dexmedetomidine on delirium and agitation in patients in intensive care: systematic review and meta-analysis with trial sequential analysis. Anaesthesia. 2019;74(3):380\u201392.","journal-title":"Anaesthesia"},{"issue":"5","key":"1861_CR76","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1007\/s10753-014-9906-1","volume":"37","author":"H Xiang","year":"2014","unstructured":"Xiang H, Hu B, Li Z, et al. Dexmedetomidine controls systemic cytokine levels through the cholinergic anti-inflammatory pathway. Inflammation. 2014;37(5):1763\u201370.","journal-title":"Inflammation"},{"issue":"3","key":"1861_CR77","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/1440-1681.12711","volume":"44","author":"YF Yang","year":"2017","unstructured":"Yang YF, Peng K, Liu H, et al. Dexmedetomidine preconditioning for myocardial protection in ischaemia-reperfusion injury in rats by downregulation of the high mobility group box 1-toll-like receptor 4-nuclear factor kappaB signalling pathway. Clin Exp Pharmacol Physiol. 2017;44(3):353\u201361.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"6","key":"1861_CR78","volume":"14","author":"J Fondeur","year":"2022","unstructured":"Fondeur J, Escudero Mendez L, Srinivasan M, et al. Dexmedetomidine in Prevention of Postoperative Delirium: A Systematic Review. Cureus. 2022;14(6): e25639.","journal-title":"Cureus"},{"issue":"4","key":"1861_CR79","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.21037\/apm-21-1989","volume":"11","author":"J Gaertner","year":"2022","unstructured":"Gaertner J, Fusi-Schmidhauser T. Dexmedetomidine: a magic bullet on its way into palliative care \u2013 a narrative review and practice recommendations. Ann Palliat Med. 2022;11(4):1491\u2013504.","journal-title":"Ann Palliat Med"},{"issue":"5","key":"1861_CR80","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1755-5949.2010.00173.x","volume":"17","author":"MJ Simone","year":"2011","unstructured":"Simone MJ, Tan ZS. The role of inflammation in the pathogenesis of delirium and dementia in older adults: a review. CNS Neurosci Ther. 2011;17(5):506\u201313.","journal-title":"CNS Neurosci Ther"},{"key":"1861_CR81","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41582-022-00698-7","volume":"18","author":"TG Fong","year":"2022","unstructured":"Fong TG, Inouye SK. The inter-relationship between delirium and dementia: the importance of delirium prevention. Nat Rev Neurol. 2022;18:579\u201396.","journal-title":"Nat Rev Neurol"},{"key":"1861_CR82","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1002\/alz.12341","volume":"17","author":"AB Lopez-Rodriguesz","year":"2021","unstructured":"Lopez-Rodriguesz AB, Hennessy E, Murray CL, et al. Acute systematic inflammation exacerbates neuroinflammation in Alzheimer\u2019s disease: IL-1b derives amplified responses in primed astrocytes and neuronal network dysfunction. Alzheimers Dement. 2021;17:1735\u201355.","journal-title":"Alzheimers Dement"},{"issue":"8","key":"1861_CR83","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S1474-4422(15)00101-5","volume":"14","author":"TG Fong","year":"2015","unstructured":"Fong TG, Davis D, Growdon ME, et al. The interface between delirium and dementia in elderly adults. Lancet Neurol. 2015;14(8):823\u201332.","journal-title":"Lancet Neurol"},{"key":"1861_CR84","doi-asserted-by":"publisher","first-page":"204512532311984","DOI":"10.1177\/20451253231198462","volume":"13","author":"M Faeder","year":"2023","unstructured":"Faeder M, Hale E, Hedayati D, et al. Preventing and treating delirium in clinical settings for older adults. Ther Adv Psychopharmacol. 2023;13:20451253231198464.","journal-title":"Ther Adv Psychopharmacol"},{"key":"1861_CR85","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13054-023-04413-w","volume":"27","author":"OJ Lieberman","year":"2023","unstructured":"Lieberman OJ, Douglas VC, LaHue SC. Reexamining cholinesterase inhibitors for the prevention and treatment of delirium in high-risk populations. Crit Care. 2023;27:129.","journal-title":"Crit Care"},{"issue":"2","key":"1861_CR86","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1017\/S1041610207006205","volume":"20","author":"N Mukadam","year":"2008","unstructured":"Mukadam N, Ritchie C, Sampson E. Chiolinesterase inhibitors for delirium: What is the evidence? Int Psychogeriatr. 2008;20(2):209\u201318.","journal-title":"Int Psychogeriatr"},{"key":"1861_CR87","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41572-020-00223-4","volume":"6","author":"JE Wilson","year":"2020","unstructured":"Wilson JE, Mart MF, Cunningham C, et al. Delirium. Nat Rev Dis Primers. 2020;6:90.","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"1861_CR88","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jpsychores.2008.05.020","volume":"65","author":"N Gupta","year":"2008","unstructured":"Gupta N, de Jonghe J, Schieveld J, et al. Delirium phenomenology: what can we learn from the symptoms of delirium? J Psychosom Res. 2008;65(3):215\u201322.","journal-title":"J Psychosom Res"},{"key":"1861_CR89","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s10354-010-0787-0","volume":"160","author":"B Iglseder","year":"2010","unstructured":"Iglseder B, Dovjak P, Benvenuti-Falger U, et al. Medikamenten-induzierte Delirien \u00e4lterer Menschen. Wien Med Wochenschr. 2010;160:281\u20135.","journal-title":"Wien Med Wochenschr"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-024-01861-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-024-01861-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-024-01861-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T08:04:28Z","timestamp":1748592268000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-024-01861-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":89,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["1861"],"URL":"https:\/\/doi.org\/10.1007\/s11096-024-01861-4","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,19]]},"assertion":[{"value":"7 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AEW, is an Associate Editor of the International Journal of Clinical Pharmacy. She had no role in handling the manuscript, specifically the processes of editorial review, peer review and decision making. GBP, RM, IT, PSG and FJ declare that they have no potential conflicts of interest that might be relevant to the contents of this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}